S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q2 2023

RTW Investments

Period: Q2 2023 Β· Filed: 2023-08-14
View on SEC EDGAR β†—
AUM
$5.25B
Total portfolio value
Positions
62
Reported securities
Top Holding
IMCR
6.9% $361.5M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
IMCRIMMUNOCORE HLDGS PLC$361.5M6.88%$59.96$32.50-45.8%
6.9%
RCKTROCKET PHARMACEUTICALS INC$351.5M6.69%$19.87$3.84-80.7%
6.7%
ALNYALNYLAM PHARMACEUTICALS INC$319.7M6.09%$189.94$312.78+64.7%
6.1%
AXSMAXSOME THERAPEUTICS INC$307.9M5.86%$71.86$244.31+240.0%
5.9%
PTCTPTC THERAPEUTICS INC$294.3M5.60%$40.67$83.31+104.8%
5.6%
RAREULTRAGENYX PHARMACEUTICAL IN$249.3M4.75%$46.13$33.47-27.4%
4.8%
MASIMASIMO CORP$247.1M4.70%$164.55β€”
4.7%
ACADACADIA PHARMACEUTICALS INC$234.3M4.46%$23.95$25.97+8.4%
4.5%
PENPENUMBRA INC$231.7M4.41%$344.06$318.57-7.4%
4.4%
BRKRBRUKER CORP$218.8M4.16%$73.05$61.64-15.6%
4.2%
ARGXARGENX SE$187.9M3.58%$389.73$939.68+141.1%
3.6%
ESTAESTABLISHMENT LABS HLDGS INC$171.1M3.26%$68.61$89.25+30.1%
3.3%
MRTXMIRATI THERAPEUTICS INC$161.6M3.08%β€”β€”
3.1%
TMOTHERMO FISHER SCIENTIFIC INC$151.5M2.88%$516.77$523.44+1.3%
2.9%
PTGXPROTAGONIST THERAPEUTICS INC$149.6M2.85%$27.62$131.62+376.5%
2.9%
NTRANATERA INC$127.1M2.42%$48.66$279.32+474.0%
2.4%
VCELVERICEL CORP$123.7M2.35%$37.57$46.98+25.1%
2.4%
CLDXCELLDEX THERAPEUTICS INC NEW$117.5M2.24%$33.93$38.37+13.1%
2.2%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$112.2M2.14%β€”β€”
2.1%
HZNPHORIZON THERAPEUTICS PUB L$102.8M1.96%β€”β€”
2.0%
CYTKCYTOKINETICS INC$84.0M1.60%$32.62$86.49+165.1%
1.6%
TXG10X GENOMICS INC$81.7M1.56%$55.84$39.01-30.1%
1.6%
RNAMAVIDITY BIOSCIENCES INC$74.2M1.41%β€”β€”
1.4%
ILMNILLUMINA INC$70.5M1.34%$182.38$188.68+3.5%
1.3%
ISRGINTUITIVE SURGICAL INC$58.1M1.11%$341.94$426.01+24.6%
1.1%
MDGLMADRIGAL PHARMACEUTICALS INC$51.2M0.97%$231.00$528.10+128.6%
1.0%
STOKSTOKE THERAPEUTICS INC$46.7M0.89%$10.63$32.70+207.6%
0.9%
TARSTARSUS PHARMACEUTICALS INC$46.0M0.88%$18.07$65.44+262.1%
0.9%
AXNXAXONICS INC$44.7M0.85%β€”β€”
0.8%
OBIOORCHESTRA BIOMED HLDGS INC$39.3M0.75%$7.00$4.19-40.1%
0.8%

Quarter-on-Quarter Activity

Q2 2023 vs. Q1 2023

New Positions (8)

TickerIssuerNotionalSince Filing
HZNPHORIZON THERAPEUTICS PUB L$102.8M
ISRGINTUITIVE SURGICAL INC$58.1M+24.6%
MDGLMADRIGAL PHARMACEUTICALS INC$51.2M+128.6%
MRUSMERUS N V$27.7M
INSMINSMED INC$21.1M
SLRNACELYRIN INC$20.4M
MRVIMARAVAI LIFESCIENCES HLDGS I$19.1M
DSGNDESIGN THERAPEUTICS INC$9.8M

Exited Positions (8)

TickerIssuerNotional
RXDXPROMETHEUS BIOSCIENCES INC$351.2M
VTYXVENTYX BIOSCIENCES INC$46.5M
ALLKALLAKOS INC$5.9M
CSTLCASTLE BIOSCIENCES INC$5.9M
JSPRXXXXJASPER THERAPEUTICS INC$4.2M
THRDTHIRD HARMONIC BIO INC$2.2M
LSBYS BIOPHARMA CO LTD$0.6M
SGHTSIGHT SCIENCES INC$0.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
BRKRBRUKER CORP$125.2M+149.3%-15.6%
TXG10X GENOMICS INC$29.9M+57.4%-30.1%
RAREULTRAGENYX PHARMACEUTICAL IN$78.1M+26.6%-27.4%
MRTXMIRATI THERAPEUTICS INC$26.2M+22.8%
ACADACADIA PHARMACEUTICALS INC$79.2M+18.7%+8.4%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$59.6M+18.6%
PTGXPROTAGONIST THERAPEUTICS INC$43.8M+17.7%+376.5%
GHGUARDANT HEALTH INC$7.8M+16.2%

Trimmed (1)

TickerIssuerNotionalShares Ξ”
APYXAPYX MEDICAL CORPORATION$-0.8M-47.7%
← Back to Hedge Funds